is tirzepatide for type 2 diabetes Peptide of the Week: Tirzepatide, a Game Changer and Obesity Management A new real-world study from

According to research, data from trials like STEP 1 and SUSTAIN 8 indicates that approximately 40% of the weight lost by patients taking semaglutide can be attributed to lean mass, primarily muscle tissue, raising concerns about potential cardiovascular and bone health risks due to muscle loss

The medication starts with an initial dose of 2.5 mg weekly with possible increments in 2.5 mg steps to a maximum of 15 mg

Both are injectable medications originally developed for type 2 diabetes that also produce significant weight loss

All medical services are provided through our affiliated medical group, Weight Watchers Clinic

What if my syringe does not have a 60-unit marking

For a detailed comparison of semaglutide versus tirzepatide beyond side effects, including efficacy, dosing, and weight loss data, our dedicated comparison page covers the full picture